A new test for diagnosing and predicting Type 1 Diabetes
Point-of-Care Assay for Type 1 Diabetes Diagnosis and Prognostication
['FUNDING_SBIR_1'] · ELECTRONIC BIOSCIENCES, INC. · NIH-10721535
This study is working on a quick and easy test to find early signs of Type 1 Diabetes in kids by checking for certain antibodies, so doctors can help them sooner, even before they feel sick.
Quick facts
| Phase | ['FUNDING_SBIR_1'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | ELECTRONIC BIOSCIENCES, INC. (nih funded) |
| Locations | 1 site (SAN DIEGO, UNITED STATES) |
| Trial ID | NIH-10721535 on ClinicalTrials.gov |
What this research studies
This research focuses on developing a point-of-care assay to detect autoantibodies associated with Type 1 Diabetes (T1D) in children. By utilizing advanced nanopore technology, the goal is to create a rapid and efficient test that can be performed outside of traditional laboratory settings. This approach aims to identify T1D early, even before symptoms appear, allowing for timely intervention and management. The project builds on previous findings that screening for these autoantibodies can significantly reduce severe complications associated with T1D.
Who could benefit from this research
Good fit: Ideal candidates for this research are children aged 0-11 years who are at risk for developing Type 1 Diabetes.
Not a fit: Patients who are already diagnosed with Type 1 Diabetes or those outside the age range of 0-11 years may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to earlier diagnosis and better management of Type 1 Diabetes in children, potentially delaying the onset of insulin dependence.
How similar studies have performed: Previous studies have shown that screening for T1D autoantibodies can effectively reduce severe complications, indicating that this approach has a foundation of success.
Where this research is happening
SAN DIEGO, UNITED STATES
- ELECTRONIC BIOSCIENCES, INC. — SAN DIEGO, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: ERVIN, ERIC — ELECTRONIC BIOSCIENCES, INC.
- Study coordinator: ERVIN, ERIC
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Autoimmune Diseases, autoimmune disorder, autoimmunity disease